The DOI matches its Crossref record.
How artificial intelligence is changing drug discovery
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AI is, for example, the major driver behind the current trend toward personalized medicine, with treatments being tailored to each patient's specific biological profile (Fleming, 2018;Lichfield, 2018).”
From Artificial Intelligence and Management: The Automation–Augmentation Paradox (2021) · cites this paper as Fleming, 2018
Experimental — accuracy not yet measuredIn the citing paper
“Many more examples are available [3,32,33,34,35,36,37], showing that AI-based methods can accelerate the drug discovery process and enable the development of more effective medications.”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sorted by citations
Items 501–544 of 544
The Changing Face of Drug and Materials Discovery
Sukumar, N. (2025) · Progress in theoretical chemistry and physics · doi:10.1007/978-3-031-85167-4_13
41Chapter 2 Methods of obtaining drugs from medicinal and aromatic plants
Özbaş, İ. Y., Pacifico, S., & Özbaş, E. (2025) · De Gruyter eBooks · doi:10.1515/9783111469713-002
Artificial Intelligence and Coronaviruses
Rehman, S. U., Shafqat, F., Khan, M. R., Zeb, A., Ahmad, I., & Niaz, K. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815322194125010013
Singh, R., Pandey, P., Kumar, A., & Mishra, M. K. (2025) · Current Bioinformatics · doi:10.2174/0115748936370246250903052830
Giavina-Bianchi, B., Bianchi, M. G., Wolosker, N., Amaro, E., & Machado, B. S. (2025) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2025ao1401 · Cited by 1
Chen, W. (2020) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-64113-899-420251002
Jebreen, K., RADWAN, E. S., Rebai, W. K., Alattar, E., Radwan, A., Safi, W., Radwan, W., & Alajez, M. (2024) · Figshare · doi:10.6084/m9.figshare.26717358
Jebreen, K., RADWAN, E. S., Rebai, W. K., Alattar, E., Radwan, A., Safi, W., Radwan, W., & Alajez, M. (2024) · Figshare · doi:10.6084/m9.figshare.26717355
Jebreen, K., RADWAN, E. S., Rebai, W. K., Alattar, E., Radwan, A., Safi, W., Radwan, W., & Alajez, M. (2024) · Figshare · doi:10.6084/m9.figshare.25770556
Jebreen, K., RADWAN, E. S., Rebai, W. K., Alattar, E., Radwan, A., Safi, W., Radwan, W., & Alajez, M. (2024) · Figshare · doi:10.6084/m9.figshare.25770366
Will AI revolutionize drug development? Researchers explain why it depends on how it’s used
Sun, D., & Macedonia, C. R. (2025) · doi:10.64628/aai.eswpw4fcc
Fatima, N. (2024) · Bulletin of Pharmaceutical & Medicinal Research · doi:10.58398/0005.000013
Simeonova, I., & Antonova, D. (2025) · International Conference on Energy Efficiency and Agricultural Engineering (EE&AE) · doi:10.1109/eeae65901.2025.11273647
“…et al. [18]; Kunapuli et al. [21]; Fleming et al. [22]; Hay et al. [23]; drug discovery (Álvarez-Machancoses & Fernández-Martí-nez [12]; Fleming [22]); epidemiology - Hay et al.[23]; personalized medicine (Barton et al. [24]; Cowie et al. [25]; Dudley et al.) and operational efficiency (Lu &…”
Lee, S.-U., & Lee, Y.-S. (2025) · The Journal of the Korean Orthopaedic Association · doi:10.4055/jkoa.2025.60.4.233
Catalyzing Drug Discovery Using Artificial Intelligence With Traditional Medicine
Taktaz, F., & Ghoran, S. H. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3373-5258-9.ch002
Du, R., Mancheong, F. U. N. G., Yuanjia, H. U., & Dongyang, L. I. U. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.12.699148
“However, the recent explosion of bio-medical data has catalyzed a paradigm shift toward computational mining as a more deliberate and data -driven strategy 5 .”
Integrating Ethics into Medical AI Development: A Proposed Framework
Malik, S., Qureshi, I., & Shah, H. (2024) · Asian Journal of Ethics in Health and Medicine · doi:10.51847/sefn97x9zz
Wang, H., Chen, L., Zhang, S., Ju, M., Feng, J., Tang, Z., Li, J., El-Seedi, H. R., & Wang, Y. (2026) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2026.2634522
“…artificial intelligence (AI) and graph-based computational methods have emerged as transformative tools in drug discovery, facilitating target identification and the prediction of compound efficacy and toxicity (Fleming 2018; Sellwood et al. 2018; Chan et al. 2019; Jiménez-Luna et al. 2020).”
Book Review: Strategic Pharmaceutical Marketing Management in Growth
Noval, M., & Sofa, N. (2026) · Journal of Sustainable Forestry · doi:10.1080/10549811.2026.2646696
Liu, M., Xu, J., & Liu, J. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag116
Persistent Local Laplacian Prediction of Protein–Ligand Binding Affinities
Liu, J., & Feng, H. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c02460 · Cited by 1
Manoharan, S., Santhakumar, A., & Perumal, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44121-9.00010-x
How does AI accelerate firm innovation? The mediating role of resource reconfiguration
Zhang, Y., Xiong, S., Zhang, L., & Guo-hu, X. (2026) · Journal of Knowledge Management · doi:10.1108/jkm-06-2025-0952
Artificial intelligence and antiaging research
Arumugam, S., Muthuvel, R., Antony, B. S., Chandrasekaran, K., & Subbaraj, G. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33159-6.00009-6
Artificial intelligence for drug discovery and development
Mashaqbeh, H., Shakhatreh, G., & Daghmash, R. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27638-5.00014-6
Determination of Anticancer Properties of Leaf Extract: An In Silico Approach
Si, Z., Xu, N., & Chen, P. (2026) · Methods and protocols in food science · doi:10.1007/978-1-0716-5226-8_28
A Review Study on the Discovery & Development of Medicine Using the Machine Learning
Kumar, K., & Saxena, A. (2026) · Lecture notes in networks and systems · doi:10.1007/978-3-032-19182-3_2
AI Regulations in Medical Devices
Khinvasara, T. (2026) · Springer handbooks · doi:10.1007/978-3-032-01636-2_40
Transformative impacts: Artificial intelligence in healthcare
Tisha, Khatun, S. I., & Bhardwaj, S. (2026) · AIP conference proceedings · doi:10.1063/5.0329192
Lozano-García, M., Codina, J.-R., Mascini, M., Dikici, E., Deo, S. K., Nichols, J. E., Azar, S. R., & Daunert, S. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.06.020
Zemnou, C. T., Ngakam, R., Tepap, S. S. D., Simo, F. B. N., Zanchi, F. B., Seukep, A. J., Kouam, A. F., & Huy, N. T. (2026) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2026.111832
Artificial Intelligence, Alliances, and Innovation1
Lou, B., & Rawley, E. (2026) · MIS Quarterly · doi:10.25300/misq/2026/19132
AI-Enabled Discovery and Sustainable Access to Biopharmaceuticals
Monisha, B., & Valarmathi, R. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-2600-2691-5.ch014
57Chapter 4 AI-Enhanced Drug Discovery and Development
Verma, P., Duhan, P., Bansal, P., Verma, K. S., Mohan, N., & Kumar, P. (2026) · De Gruyter eBooks · doi:10.1515/9783112214275-004
Khan, S., Samuelsson, J. G., Cai, X., Natarajan, K., & Madhavan, S. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104754
Prasad, S. T., Ganesan, P., Prasad, T. V. S. G., Vadivel, M., Sivakumar, V. G., & Prasad, D. S. (2026) · AIP conference proceedings · doi:10.1063/5.0330700
Herbetko, K., Herbetko, K., Mikołajek, M., Wojdyło, L., Klasen, K., Kulbacki, M., & Kulbacka, J. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2714025 · Cited by 1
Artificial Intelligence: Shaping Next Generation Oncotherapy
Tejashwini, K., Thota, S., Himabindu, V., Maneesha, N., & Bhukya, B. (2026) · Cancer Bioscience · doi:10.1016/j.cbs.2026.100007
Wu, W., Li, Y., Cai, X., & Li, J. (2026) · IEEE Access · doi:10.1109/access.2026.3732159
“Developing a new drug currently costs about 2.8 billion US dollars, typically requires more than ten years, and still carries a high risk of failure [6], [7], [8].”
InfluentialAmmari, M. E., Bouzakraoui, S., Mrabti, I., Kaoutar, F., Boukita, H., Idrissi, A., Najiba, B., & Ziri, R. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103920
Jahan, I., Yimer, H. L., Badal, K., et al. (2026) · Frontiers in Chemistry · doi:10.3389/fchem.2026.1913090
The role of artificial intelligence in overcoming animal testing
Hartung, T., Luechtefeld, T., & Maertens, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26514-3.00007-2
Metadata
- Authors
- Fleming, N.
- Corresponding author
- Fleming, Nic
- Venue
- Nature
- Published
- 2018-05-30
- Volume
- 557
- Issue
- 7707
- Pages
- S55-S57
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2806834952
- Cited by
- 546
- References
- 0
- Citations by year
- 2026: 41 · 2025: 49 · 2024: 81 · 2023: 95 · 2022: 97 · 2021: 81 · 2020: 56 · 2019: 38 · 2018: 7
- FWCI
- 34.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Keywords
- artificial intelligence, drug discovery, machine learning, pharmaceuticals, computer-aided drug design
- MeSH terms
- Machine Learning, Algorithms, Amyotrophic Lateral Sclerosis, Animals, Artificial Intelligence, Automation, Drug Industry, Humans, Neoplasms, Pattern Recognition, Automated, Robotics, Efficiency, Organizational, Mice, Drug Discovery, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
